Table 2.
Biological Activity | Type of Extract | Concentration/Dose | Model Assay | Main Results | Ref. |
---|---|---|---|---|---|
In vitro | |||||
Antioxidant | Water-methanol-acetone | NI | DPPH• and ABTS+ scavenging and FRAP |
Extracts exhibited antioxidant properties | [35] |
Decoction and cold infusions | NI | Briggs–Rauscher oscillating reaction |
Beverages exhibited antioxidant properties | [55] | |
Antihypertensive | Anthocyanin-rich fraction | 84.5 µg/mL | ACE inhibitory assay | Fraction exhibited ACE inhibitory activity in a dose-dependent response | [34] |
Vasorelaxant | Hexane-ethyl acetate-methanol | 0.01 to 2 mg/mL | Rat aorta tissue | Fractions showed vasorelaxant effects by inhibition of Ca+ influx | [57] |
Antidiabetic | Aqueous | IC50 of 25.2 and 187 µg/mL, respectively | α-amylase and α-glucosidase inhibition assay | The extract exhibited higher α-amylase inhibitory activity than α-glucosidase | [56] |
Cardioprotective | Aqueous | 7 to 500 µg/mL | Doxorubicin-induced cytotoxicity in rat heart-derived myoblast H9c2 cardiac myocyte cells | The extract exhibited a protective effect on cardiomyocytes, increasing cell viability and decreasing cell apoptosis | [58] |
Antibacterial | Aqueous-methanolic | 20 mg/L | Staphylococcus aureus, Escherichia coli, Klebsiellapneumoniae, and Bacillus cereus | The extract exhibited potent antimicrobial activity against Gram-negative bacteria | [59] |
Antiviral | Aqueous decoction | 100 mg/mL | Feline calicivirus, murine norovirus, and hepatitis A virus | Extracts showed antiviral activity to undetectable levels | [60] |
Antiproliferative | Methanolic | 0.2 to 1 mg/mL | Murine melanoma cell line (B16-F1) and human umbilical vein endothelial cells | Extract inhibits melanoma cell growth, migration, and tube formation in a dose-dependent response | [8] |
Cytotoxic | Aqueous | 0.05 to 0.5 mg/mL | Human breast cancer (MCF-7) cell line | The extract showed selective cytotoxic activity in a dose-dependent manner | [61] |
In vivo | |||||
Neuroprotective | Aqueous decoction | 500 mg/kg bw for 24 days before BCCAO | Ischemic brain injury-induced adult male Wistar rats | The extract showed protective effects against neuronal damage induced by BCCAO | [62] |
Ethanolic | 200 to 500 mg/kg bw | Cypermethrin-induced oxidative stress in mice Mus musculus | The extract showed protective effects against toxicity induced by cypermethrin | [71] | |
Sedative | Maceration in hot water | 100 to 400 mg/kg bw | Apomorphine-induced stereotypic behavior test using Swiss albino mice | HSE significantly reduced the exploratory behavior in mice, similar to diazepam | [63] |
Antianxiety | Ethyl acetate fractions | 5 to 30 mg/kg bw | Elevated plus-maze rat model | HS fraction reduced anxiety at low concentrations | [64] |
Antidepressant | Ethyl acetate fractions | 5 to 30 mg/kg bw | Porsolt’s forced swim test in rats | HS fraction exhibited antidepressant properties at doses of 20 mg/kg | [64] |
Hepatoprotective | Aqueous extract | 100 to 200 mg/kg bw | Wistar rats injected with 2,4-dinitrophenylhydrazine (DNPH) | The extract inhibited the toxicity of DNPH in a dose-dependent response similar to the control drug | [65] |
Cardioprotective | Polyphenol-rich extract | 100 mg/kg bw | Hyperglycemia-induced cardiac oxidative stress rats | The extract ameliorated oxidative stress damage in diabetic heart | [32] |
Antihyperinsulinemic | Aqueous | 50 to 200 mg/kg bw | High fructose diet-induced insulin resistance rats | The extract showed a similar effect to metformin, an oral antidiabetic drug | [66] |
Antidiabetic | Aqueous | 30 mg/mL | Alloxan-induced diabetic rat | The extract showed hypoglycemic and antioxidant effects | [72] |
Anti-obesity | HS by-products | 10 g/100 g HF/HFr diet | HF/HFr-induced rats | HS by-products reduced adipocyte hypertrophy, insulin resistance, and hepatic steatosis | [67] |
Antihypertensive | Aqueous | 6 mg/mL bw | Salt hypertensive-induced rats | The extract attenuated the development of salt-induced hypertension | [73] |
Anti-inflammatory | Methanolic | 100 to 400 mg/kg bw | Paw edema-induced rat | The extract significantly reduced the paw size edema in a dose-dependent manner in less time than aspirin | [68] |
Hypolipidemic | Aqueous | 500 to 1000 mg/kg bw | Hypercholesterolemic rats | The extract exhibited hypolipidemic effects in a dose-dependent response | [74] |
Renal function improvement | Aqueous | 2 g/L | Metabolic syndrome-induced rats | The extract decreased oxidative stress and promoted normal renal function | [30] |
Anti-ulcer | Aqueous | 100 to 800 mg/kg bw | Indomethacin-induced gastric ulcer rats | The extract exhibited a protective effect against induced gastric ulcer | [70] |
Antianemic | Aqueous | 200 mg/kg bw | Healthy rats | The extract improved hematological parameters | [69] |
NI: no information; BW: body weight; DPPH•: 2,2-diphenyl-1-picrylhydrazyl radical; ABTS+: 2,2′-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid); FRAP: ferric reducing antioxidant power; BCCAO: bilateral common carotid artery occlusion; HF/HFr: high-fat high fructose diet.